US Stock MarketDetailed Quotes
SMMT Summit Therapeutics
- 20.100
- -1.800-8.22%
Close Oct 1 16:00 ET
- 20.080
- -0.020-0.10%
Post 20:02 ET
14.77BMarket Cap-182727P/E (TTM)
21.840High19.750Low3.81MVolume21.630Open21.900Pre Close78.41MTurnover3.71%Turnover RatioLossP/E (Static)734.89MShares33.89052wk High75.85P/B2.07BFloat Cap1.64052wk Low--Dividend TTM102.81MShs Float33.890Historical High--Div YieldTTM9.54%Amplitude0.660Historical Low20.568Avg Price1Lot Size
Summit Therapeutics Stock Forum
Sign in to post a comment
$SMMT 250117 20.00P$
i will shot this till $15
i will shot this till $15
1
2
Here are the levels to watch on SMMT. Curling off the 23.33 level which lines up with the .50 fib. If that holds watch for a retest of 26.50 first. If it doesn't watch for a test of 19.72.
Larger Image: tradingview.com...
$Summit Therapeutics (SMMT.US)$
Larger Image: tradingview.com...
$Summit Therapeutics (SMMT.US)$
3
$Summit Therapeutics (SMMT.US)$
10 clinical trials to watch in the second half of 2024 | BioPharma Dive
10 clinical trials to watch in the second half of 2024 | BioPharma Dive
$Summit Therapeutics (SMMT.US)$ Looking for get in, this is very great stock, it already in my watchlist when it still only 8dollars, hope to get in at 15dollars sooner or later although it seems quite impossible to pullback that much, but that's my preferable buying price.
3
1
$Summit Therapeutics (SMMT.US)$ it's time to run away
1
3
$Summit Therapeutics (SMMT.US)$ Akeso up 8% on HKEX.
1
$Summit Therapeutics (SMMT.US)$surged 123.4% this week after its lung cancer drug Ivonescimab outperformed Keytruda in a phase 3 clinical trial. The trial, conducted with its partner Akeso in China, showed superior progression-free survival for patients with PD-L1 gene expression.
Analysts raised price targets for Summit, speculating that Ivonescimab could challenge Keytruda in the $50 billion lung cancer drug market. Summit also raised $235 mill...
Analysts raised price targets for Summit, speculating that Ivonescimab could challenge Keytruda in the $50 billion lung cancer drug market. Summit also raised $235 mill...
3
This Might be my first 5-10 bags, (on this app)
Still pretty strong, technically, catalyst is there, private placement, insiders buying, retailers only have it for 3% supply...
simple when the supply is limited, the price is going up...
The product is anti cancer drug... this cancer thing will be huge in the future... Imagine human finally find a way to cure or treat the disease...
It's a prediction and a prayer, may everyone got gain.
$Summit Therapeutics (SMMT.US)$
$SMMT 240920 40.00C$
Still pretty strong, technically, catalyst is there, private placement, insiders buying, retailers only have it for 3% supply...
simple when the supply is limited, the price is going up...
The product is anti cancer drug... this cancer thing will be huge in the future... Imagine human finally find a way to cure or treat the disease...
It's a prediction and a prayer, may everyone got gain.
$Summit Therapeutics (SMMT.US)$
$SMMT 240920 40.00C$
10
7
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Xu Lois : why
KingNY-Life Xu Lois : Do you believe this too?